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age within the context of HNPCC to suggest that it is
part of the disease spectrum.
The results that were obtained reflect breast cancer
incidence observed in our population.We cannot explain
why the findings for our population differ from those
observed in the Dutch families with HNPCC or those
reported by Watson et al. (1993) or Aarnio et al. (1999),
who showed that there was no increased risk of breast
cancer in HNPCC. In the analysis of Dutch families
with HNPCC, either no association or indeed a slight
protective effect of DNA mismatch-repair errors was
reported.
There are several interesting differences between our
population and the Dutch population. The most inter-
esting is the relative percentage of families with linkage
to hMSH2 and hMLH1. In Holland, the ratio of hMSH2
to hMLH1 mutation carriers is ∼1:1, compared with
our findings, which suggest a 1:2 ratio of hMSH2 to
hMLH1 mutations. This difference does not account for
the discrepancy seen between our population and the
Dutch population, but it does suggests that there are
significant differences between the two. We are currently
accumulating more HNPCC families (1230) and will re-
analyze the data when mutation analysis is complete, to
determine whether the results of our initial analysis of
the first 95 families hold true or were a result of a bias
within our population.
Finally, we agree with the notion put forward byVasen
et al. (2001) that breast cancer development may be
accelerated in persons who are deficient in DNA mis-
match repair.
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Mitochondria and the Quality of Human Gametes
To the Editor:
Ruiz-Pesini et al. (2000) cleverly show that extant hu-
man mtDNA variation affects sperm function. They find
that mitochondrial haplogroup T is overrepresented in
asthenozoospermic populations and shows reduced
sperm oxidative phosphorylation pathway (OXPHOS)
activity, relative to the H haplogroup that is over-
represented in nonasthenozoospermic populations.
These authors—as well as Moore and Reijo-Pera (2000),
in the accompanying invited editorial—stress that, be-
cause of the exclusive matrilinear inheritance of mito-
chondria, mutations of mtDNA purely affecting male
fertility are not selected against and therefore can be-
come fixed. The absence of a direct check against mi-
tochondrial mutations that affect male fertility is un-
fortunate and begs the question of why such a pattern
became established.
In keeping with an earlier suggestion (Giannelli 1986),
I propose that the exclusion of spermmitochondria from
the zygote is part of a scheme enabling mitochondria to
provide an indirect measure of sperm quality and, hence,
to favor fertilization by optimal spermatozoa while
avoiding the risk of passing on mtDNA exposed to
high physiological stress and, hence, potential damage.
This would clearly have adaptive value and could help
justify the establishment of matrilineal mitochondrial
inheritance.
There is evidence that mitochondria have a role in
germ-cell selection. Krakauer and Mira (1999), in a
phylogenetic study, note that species producing fewer
offspring have fewer egg mitochondria and experience
greater ovarian atresia, and these authors conclude that
lower numbers of mitochondria offer greater opportu-
nities for variation in mitochondrial function and, thus,
for elimination of eggs with poor mitochondria. This
results in purifying selective pressure on mitochondrial
genomes. Some proof of a mitochondrial role in ovarian
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atresia exists, as microinjection of 5# 103 mitochondria
from nonapoptotic follicular granulosa rescues the oo-
cytes from FVB-strain mice that undergo an inherently
high rate of apoptosis in vitro (Perez et al. 2000). With
regard to spermatozoa, Ruiz-Pesini et al. (2000) provide
direct evidence that mitochondrial function is critical to
their motility and hence presumably to their success
in fertilization.
Nevertheless, egg and sperm differ dramatically in
their mitochondrial complement, since the human oo-
cyte has 106 mtDNA molecules, whereas mature sper-
matozoa have only 100 (Cummings 1998). It follows
that spermatozoa should be exquisitely sensitive to mi-
tochondrial malfunction.
I suggest that this allowsmitochondria to becomeboth
a sensitive meter of genetic damage to sperm and the
means of selecting, at fertilization, spermatozoa derived
from the germ-cell lines that have best preserved the
quality of their genome during postzygotic life.However,
reliance on a small complement of mitochondria to pro-
duce very high levels of kinetic energy in conditions of
unusually high oxygen tension in the female genital tract
exposes sperm mtDNA to extraordinary risks from ox-
ygen radicals, and, therefore, the disposal of mtDNA at
zygote formation also seems advantageous. To provide
a sensitive, indirect measure of the quality of the sperm
genome, the mitochondrial complement of a spermato-
zoon must meet two conditions: it should not afford a
high degree of functional redundancy, and it must offer
a target for deleterious mutations larger than the nuclear
genome.
The results of Ruiz-Pesini et al. (2000) suggest that
the former is true, because a mitochondrial haplogroup
associated with modest OXPHOS deficit is associated
with asthenozoospermia. More-direct experimental ev-
idence on this point would require the inactivation of a
proportion of the mitochondria and subsequent exam-
ination of sperm function. Such evidence is not available,
but, since each human spermatozoon competes with 108
colleagues for a single oocyte, it seems probable that a
sperm needs all of the energy its 100 mitochondria can
produce.
It is reasonable to conclude that the mitochondrial
complement of a spermatozoon offers a sufficiently large
target for deleterious mutations, for the following rea-
sons. The germinal mutation rate for mtDNA is 50-fold
greater than that for genomic DNA. Human mitochon-
dria have no introns, intergenic sequences, or complex,
large centromeres and telomeres, and they have nonre-
dundant gene sequences that even show some overlap.
In contrast, nuclear coding sequences are highly dis-
persed (International Human Genome Sequencing Con-
sortium 2001) and show some degree of functional re-
dundancy. Therefore, the essential information content
of mtDNA can be considered to be at least 100-fold
greater than that of a nuclear DNA segment of similar
length. It follows that the effective target for deleterious
mutations presented by a mtDNA molecule should be
equivalent to 16,569 bp # 50 # 100 p 83 Mb of
genomic DNA. This is ∼1/36 of the haploid genome.
Therefore, the 100 mtDNA molecules of a spermato-
zoon offer a target for deleterious mutation equivalent
to 2.8 haploid genomes. Thus, if the functional redun-
dancy of the mitochondrial complement of a spermat-
ozoon, in terms of its competition with 108 other sper-
matozoa, is !2.5-fold, the mitochondrial complement of
the male gametes can provide a sensitive, indirect mea-
sure of their genetic well-being and an effective means
of sperm selection at fertilization.
This may be important in the moderation of the ge-
netic risks resulting from the production of a huge num-
ber of male gametes by large numbers of cell divisions.
Of course, the scope and consequences of sperm selec-
tion should be even greater in species with common
polyandry, where sperm from different males may com-
pete at fertilization.
Experimental evidence in favor of my hypothesis
could be sought by investigation of whether spermato-
zoa in the top grade for a relevant phenotype—for ex-
ample, mobility—show less mitochondrial damage than
those in lower grades. This would require analysis of
individual, phenotypically selected spermatozoa by
means capable of revealing mutations affecting as little
as 1 mtDNA molecule in 100. This is a hard, but not
impossible, task. It does require the mtDNA content of
a single spermatozoon to be diluted to obtain pools of
∼10 mtDNAmolecules. Then efficient and fast screening
methods, such as fluorescent solid phase mismatch cleav-
age or denaturing high-performance liquid chromatog-
raphy (DHPLC), can be used, after PCR amplification,
to detect a single mutant mtDNA molecule among the
other 10.
I hope that the above comments will stimulate interest
in the potential role of mitochondria as guardians of the
quality of the male contribution to the human zygote.
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